Award
Delivery Order #SPE2DR26F8AFJ
Pharmaceutical Delivery Order for Novolin N Vials by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$724.12
Ceiling
$724.12
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26F8AFJ
NAICS
325411
This delivery order contract represents a specific procurement action under a longstanding indefinite delivery vehicle (IDV) awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company specializing in drug supply and related services. The contract focuses on the acquisition of Novolin N insulin vials, a critical pharmaceutical product used in diabetes management, ensuring the availability of essential medication. This delivery order supports the broader scope of the parent IDV, which is aimed at sustaining long-term pharmaceutical supplies for health agencies, thereby bolstering public health initiatives. The work involves timely delivery of the specified medical product to fulfill agency needs. The contract was issued under the existing IDV arrangement, leveraging AmerisourceBergen's established role, and was awarded based on this procurement vehicle. The operation is scheduled for a short, definitive performance period, highlighting its role as a targeted supply action within a larger ongoing pharmaceutical support program.
Description
4571051303!NOVOLIN N 100 UNIT/ML VIAL 10ML